A study conducted in India by the Karnataka Research Society for the Study of Diabetes in India (KRSSDI) showed that using artificial intelligence (AI) in diabetes management can greatly improve health outcomes for patients with Type 2 diabetes.

The study investigated how AI-powered precision care, when combined with remote monitoring, can help patients manage their blood sugar and improve overall health. Over 90 days, 725 adults between ages 20 and 70 with Type 2 diabetes participated in a program that offered tailored care plans based on lab results, lifestyle, and other personal factors. Patients followed the program through a mobile app, which allowed for continuous updates and adjustments to their treatment based on their progress.

The research, spearheaded by Dr Manohar KN, Chairman of Disha India; Vijay Kumar K, Honorary Secretary of KRSSDI; and Dr Suman R, former Chairman of KRSSDI, has been accepted by the International Diabetes Federation for presentation at its 2025 conference in Bangkok. “This study demonstrates the transformative impact of AI in diabetes care. By making healthcare more precise and accessible, AI-driven approaches have the potential to greatly improve quality of life while managing Type 2 diabetes,” said Dr Manohar.

Key results
Key results of the study included a significant decrease in blood sugar levels. The average HbA1c—a measure of blood sugar control—dropped by 1.2% from an initial average of 8.8%. Fasting blood sugar and post-meal blood sugar readings also fell by 40 mg/dL and 83 mg/dL, respectively. In addition to improved blood sugar levels, patients saw notable cardio-metabolic benefits. On average, participants lost 3.8 kg, and both systolic and diastolic blood pressures were reduced by 10 mm Hg and 4 mm Hg, respectively.

The study also showed encouraging trends in medication management. Over half of the participants using insulin were able to discontinue it, and 30% reduced their insulin doses. Among those taking oral medications, 67% maintained their dosages, 25% reduced them, and 5% were able to stop medications altogether.

The researchers emphasised that AI’s role in managing diabetes goes beyond adjusting treatments. The technology provides a continuous education component, helping patients better understand and manage their condition. Remote monitoring also allows healthcare providers to offer guidance in real-time, improving the overall patient experience and engagement in self-care.